Aspects of the present application relate to pharmaceutical formulations comprising atorvastatin or pharmaceutically acceptable salts thereof and glimepiride as active agents wherein both atorvastatin or pharmaceutically acceptable salts thereof and glimepiride are in immediate release form.
